betulinic acid has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Máñez, S; Ríos, JL | 1 |
| Ajala-Lawal, RA; Ajiboye, TO; Aliyu, NO | 1 |
1 review(s) available for betulinic acid and Metabolic Syndrome
| Article | Year |
|---|---|
New Pharmacological Opportunities for Betulinic Acid.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antiviral Agents; Betulinic Acid; Cytotoxins; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Inflammation; Metabolic Syndrome; Pentacyclic Triterpenes; Triterpenes | 2018 |
1 other study(ies) available for betulinic acid and Metabolic Syndrome
| Article | Year |
|---|---|
Betulinic acid improves insulin sensitivity, hyperglycemia, inflammation and oxidative stress in metabolic syndrome rats via PI3K/Akt pathways.
Topics: Animals; Betulinic Acid; Blood Glucose; Catalase; Cholesterol; Diet; Fructose; Gene Expression Regulation; Glutathione; Glutathione Peroxidase; Hyperglycemia; Hypoglycemic Agents; Insulin; Interleukin-6; Male; Malondialdehyde; Metabolic Syndrome; Oxidative Stress; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Superoxide Dismutase; Triglycerides; Triterpenes; Tumor Necrosis Factor-alpha | 2020 |